RE:RE:News would be niceI also think that they will make an small aquisition before the end of the year. However I feel that VisionPro will turn out to be a valuable asset. Existing enterprise clients will be offered VisionPro contact and glasses(Soon). This could become a huge cross selling item. give it time. If Karen does it right it will be good.
I also feel that the Q2 cash will get hit with some one time costs , such as legal fees for the VisionPro problem and any costs associated with the departure of some executives. Im hoping that the cash remains above $35 million. This however will be topped up once again once they start selling some of the clinics.
Apart from the cash there is tremendous value in DOC at these prices. They need to hurry and show that value to the market before someone decides to make an opportunistic low bid. I think that once the new management is announced they will want to start a share buy back program. But lets work on one thing at a time. Lets get Karen and the board setup!